Ngā hua rapu - Rolf Morhart
- E whakaatu ana i te 1 - 6 hua o te 6
-
1
Neurological symptoms in individuals with fibrodysplasia ossificans progressiva mā Joseph A. Kitterman, Jonathan B. Strober, Lixin Kan, David M. Rocke, Amanda Cali, Jeannie L. Peeper, Jennifer Snow, Patricia Delai, Rolf Morhart, Robert J. Pignolo, Eileen M. Shore, Frederick S. Kaplan
I whakaputaina 2012Artigo -
2
International physician survey on management of FOP: a modified Delphi study mā Maja Di Rocco, Geneviève Baujat, Marta Bertamino, Matthew A. Brown, Carmen L. De Cunto, Patricia Delai, Elisabeth M. W. Eekhoff, Nobuhiko Haga, Edward C. Hsiao, Richard Keen, Rolf Morhart, Robert J. Pignolo, Frederick S. Kaplan
I whakaputaina 2017Artigo -
3
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1 mā Frederick S. Kaplan, Meiqi Xu, Petra Seemann, J. M. Connor, David L. Glaser, Liam Carroll, Patricia Delai, Elisabeth Fastnacht-Urban, Stephen J. Forman, Gabriele Gillessen‐Kaesbach, Julie Hoover‐Fong, Bernhard Köster, Richard M. Pauli, William Reardon, Syed-Adeel Zaidi, Michael Zasloff, Rolf Morhart, Stefan Mundlos, Jay C. Groppe, Eileen M. Shore
I whakaputaina 2008Artigo -
4
Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP) mā Edward C. Hsiao, Maja Di Rocco, Amanda Cali, Michael Zasloff, Mona Al Mukaddam, Robert J. Pignolo, Zvi Grunwald, Coen Netelenbos, Richard Keen, Geneviève Baujat, Matthew A. Brown, Tae‐Joon Cho, Carmen De Cunto, Patricia Delai, Nobuhiko Haga, Rolf Morhart, Christiaan Scott, Keqin Zhang, Robert J. Diecidue, Clive Friedman, Frederick S. Kaplan, Elisabeth M. W. Eekhoff
I whakaputaina 2018Revisão -
5
Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles mā Elisabeth M. W. Eekhoff, Ruben D. de Ruiter, Bernard J. Smilde, Ton Schoenmaker, Teun J. de Vries, Coen Netelenbos, Edward C. Hsiao, Christiaan Scott, Nobuhiko Haga, Zvi Grunwald, Carmen L. De Cunto, Maja Di Rocco, Patricia Delai, Robert J. Diecidue, Vrisha Madhuri, Tae‐Joon Cho, Rolf Morhart, Clive Friedman, Michael Zasloff, Gerard Pals, Jae‐Hyuck Shim, Guangping Gao, Frederick S. Kaplan, Robert J. Pignolo, Dimitra Micha
I whakaputaina 2022Revisão -
6
Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop mā Ruben D. de Ruiter, Bernard J. Smilde, Gerard Pals, Nathalie Bravenboer, Petra Knaus, Ton Schoenmaker, Esmée Botman, Gonzalo Sánchez‐Duffhues, Maurizio Pacifici, Robert J. Pignolo, Eileen M. Shore, Marjolein van Egmond, Hans Van Oosterwyck, Frederick S. Kaplan, Edward C. Hsiao, Paul B. Yu, Renata Bocciardi, Carmen L. De Cunto, Patricia Delai, Teun J. de Vries, Susanne Hilderbrandt, Richard T. Jaspers, Richard Keen, Peter Koolwijk, Rolf Morhart, J.C. Netelenbos, Thomas Rustemeyer, Christiaan Scott, Clemens Stockklausner, Peter ten Dijke, James T Triffit, Francesc Ventura, Roberto Ravazzolo, Dimitra Micha, Elisabeth M. W. Eekhoff
I whakaputaina 2021Revisão
Ngā utauta rapu:
Ngā marau whai pānga
Fibrodysplasia ossificans progressiva
Heterotopic ossification
Medicine
Surgery
Myositis ossificans
Pathology
Biology
Gene
Genetics
Anatomy
Bioinformatics
Disease
Intensive care medicine
Internal medicine
Mutation
Adverse effect
Bone morphogenetic protein
Bone morphogenetic protein receptor
Cartilage
Clinical trial
Delphi method
Dysgeusia
Endochondral ossification
Environmental health
Family medicine
Genetic enhancement
Headaches
Heterotopic bone
Mathematics
Missense mutation